• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVR
Click for more information
0.09% $21.05

ANTERIS TECHNOLOGIES LTD

Market Cap $404.3M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Anteris Technologies Ltd is an Australia-based company that is engaged in the research... Anteris Technologies Ltd is an Australia-based company that is engaged in the research and development (R&D) of its structural heart products. The Company is engaged in the manufacture and sale of ADAPT regenerative tissue products globally. It is focused on developing biomimetic transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis. ADAPT is the Company’s patented anti-calcification tissue technology. Its DurAVR THV is a three dimensional (3D) single piece valve and is a biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The Company also provides ComASUR Delivery System, a balloon expandable system with the ability to rotate valves for predictable alignment with the heart’s native commissure. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AVR
AGM 2024 questions - please submit here. 		16:02 33 7.4K
16:02 Last post  WilliamPike Comments Created with Sketch.  33  Views Created with Sketch.  7.4K 
AVR
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		04/05/24 43 11K
04/05/24 Last post  whytee Comments Created with Sketch.  43  Views Created with Sketch.  11K 
AVR
Ann: Notification regarding unquoted securities - AVR 		02/05/24 0 295
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

Read More   right-arrow Created with Sketch.
AUQ
10 May 2024
ALARA RESOURCES LIMITED
02/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  295 
AVR
Published paper that mentions DurAVR 		02/05/24 14 5.0K
02/05/24 Last post  PhantomGWW Comments Created with Sketch.  14  Views Created with Sketch.  5.0K 
AVR
Ann: Notice of Annual General Meeting/Proxy Form 		01/05/24 11 3.1K
01/05/24 Last post  Cosmonaut Comments Created with Sketch.  11  Views Created with Sketch.  3.1K 
AVR
Strategic Partner around the corner 		18/04/24 2 1.1K
18/04/24 Last post  MactavishNat Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
AVR
Ann: Cleansing Notice 		18/04/24 0 256
18/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  256 
AVR
Ann: Annual Report to shareholders 		18/04/24 17 5.4K
18/04/24 Last post  garthdaisy Comments Created with Sketch.  17  Views Created with Sketch.  5.4K 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - AVR
02 May 14:16
 
Notice of Annual General Meeting/Proxy Form
29 Apr 14:24
 
Cleansing Notice
18 Apr 12:05
 
Quarterly Activities/Appendix 4C Cash Flow Report
18 Apr 11:54
 
Application for quotation of securities - AVR
17 Apr 11:16
 
Application for quotation of securities - AVR
15 Apr 17:58
 
View More arrow Created with Sketch.

Featured News

RCE Recce breathes better on positive lung infection drug pilot test results
right-arrow Created with Sketch.
CMG Critical Minerals Group boosts JORC by 96% to 713Mt vanadium; others
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
AUE Aurum hits 59m gold intercept at 1.42g/t; responds to please explain
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.

(20min delay)
Last
$21.05 		Change
-0.020(0.09%) 		Mkt cap ! $404.3M
Open High Low Value Volume
$21.00 $21.05 $20.70 $193.2K 9.289K

Buyers (Bids)

No. Vol. Price($)
1 1000 $21.00
 

Sellers (Offers)

Price($) Vol. No.
$21.05 999 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
$20.93 		  Change
-0.020 ( 0.37 %)
Open High Low Volume
$20.93 $20.93 $20.93 81
Last updated 12.16pm 10/05/2024 ?
AVR (ASX) Chart

Top Stories

Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne

Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.

Featured News

WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
360 Family tracking app Life360 eyeing a US IPO as profitability approaches
right-arrow Created with Sketch.
AUE Aurum hits 59m gold intercept at 1.42g/t; responds to please explain
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.